XCHANGE TEC.INC (XHG) Fundamental Analysis & Valuation

NASDAQ:XHG • US74738J5083

Current stock price

1.4601 USD
+0.6 (+69.78%)
At close:
1.0133 USD
-0.45 (-30.6%)
After Hours:

This XHG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. XHG Profitability Analysis

1.1 Basic Checks

  • XHG had negative earnings in the past year.
  • XHG had a negative operating cash flow in the past year.
  • In the past 5 years XHG reported 4 times negative net income.
  • XHG had a negative operating cash flow in each of the past 5 years.
XHG Yearly Net Income VS EBIT VS OCF VS FCFXHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 500M -500M

1.2 Ratios

  • XHG has a Return On Assets of -1078.75%. This is amonst the worse of the industry: XHG underperforms 97.30% of its industry peers.
Industry RankSector Rank
ROA -1078.75%
ROE N/A
ROIC N/A
ROA(3y)-396.99%
ROA(5y)-96.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XHG Yearly ROA, ROE, ROICXHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 500 -500 -1K

1.3 Margins

  • XHG has a better Gross Margin (2.19%) than 85.14% of its industry peers.
  • The Profit Margin and Operating Margin are not available for XHG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XHG Yearly Profit, Operating, Gross MarginsXHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

2

2. XHG Health Analysis

2.1 Basic Checks

  • XHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for XHG has been reduced compared to 1 year ago.
  • Compared to 1 year ago, XHG has a worse debt to assets ratio.
XHG Yearly Shares OutstandingXHG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10B 20B 30B 40B
XHG Yearly Total Debt VS Total AssetsXHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • XHG has an Altman-Z score of -104.84. This is a bad value and indicates that XHG is not financially healthy and even has some risk of bankruptcy.
  • XHG has a better Altman-Z score (-104.84) than 63.51% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -104.84
ROIC/WACCN/A
WACC4.76%
XHG Yearly LT Debt VS Equity VS FCFXHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 -1B -2B

2.3 Liquidity

  • XHG has a Current Ratio of 0.04. This is a bad value and indicates that XHG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.04, XHG is in the better half of the industry, outperforming 63.51% of the companies in the same industry.
  • A Quick Ratio of 0.04 indicates that XHG may have some problems paying its short term obligations.
  • XHG has a better Quick ratio (0.04) than 63.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
XHG Yearly Current Assets VS Current LiabilitesXHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1

3. XHG Growth Analysis

3.1 Past

  • XHG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39314.29%.
  • Looking at the last year, XHG shows a very strong growth in Revenue. The Revenue has grown by 26.67%.
EPS 1Y (TTM)-39314.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)26.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.41%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XHG Yearly Revenue VS EstimatesXHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2024 2025 500M 1B 1.5B
XHG Yearly EPS VS EstimatesXHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 -200K -400K -600K -800K -1M

0

4. XHG Valuation Analysis

4.1 Price/Earnings Ratio

  • XHG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XHG Price Earnings VS Forward Price EarningsXHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XHG Per share dataXHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. XHG Dividend Analysis

5.1 Amount

  • No dividends for XHG!.
Industry RankSector Rank
Dividend Yield 0%

XHG Fundamentals: All Metrics, Ratios and Statistics

XCHANGE TEC.INC

NASDAQ:XHG (4/15/2026, 5:39:35 PM)

After market: 1.0133 -0.45 (-30.6%)

1.4601

+0.6 (+69.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap75.27M
Revenue(TTM)365.27M
Net Income(TTM)-748.41M
Analysts45
Price TargetN/A
Short Float %265.85%
Short Ratio4.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.4
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-78.83
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS1.04
BVpS-2.51
TBVpS-2.57
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1078.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.19%
FCFM N/A
ROA(3y)-396.99%
ROA(5y)-96.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover5.26
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -104.84
F-Score3
WACC4.76%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39314.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.41%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-148.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.73%
OCF growth 3YN/A
OCF growth 5YN/A

XCHANGE TEC.INC / XHG Fundamental Analysis FAQ

What is the fundamental rating for XHG stock?

ChartMill assigns a fundamental rating of 1 / 10 to XHG.


Can you provide the valuation status for XCHANGE TEC.INC?

ChartMill assigns a valuation rating of 0 / 10 to XCHANGE TEC.INC (XHG). This can be considered as Overvalued.


What is the profitability of XHG stock?

XCHANGE TEC.INC (XHG) has a profitability rating of 1 / 10.


How financially healthy is XCHANGE TEC.INC?

The financial health rating of XCHANGE TEC.INC (XHG) is 2 / 10.